Envista Holdings Corp (NVST) Stock AnalysisNVSTEnvista Holdings Corp

Envista Holdings Corporation provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a provider of a range of solutions to support dental implants, orthodontic treatments, dental diagnostics, general dental consumable products, equipment and services. Its segments include Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, lab products, and loupes. The Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

Envista Holdings Corp is a good buy right now due to its strong growth potential, evidenced by a 5% core growth in Q2 2026 and a projected adjusted EPS growth of 58%. The current price is $27.13, which is below the average analyst price target of $29, indicating potential upside. Additionally, the company has raised its 2026 core growth expectations to 3.5% to 4.5%, which supports a bullish outlook. However, the RSI is currently at 38.305, indicating that the stock may be oversold, presenting a buying opportunity.